Financial Reports
Latest Updates
Kringle Pharma,Inc. (4884) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-08-10 | 決算短信 | Financial Results for the Nine Months Ended June 30, 2026 [Japanese GAAP] (Non-consolidated) | |
| 2026-07-24 | — | Kringle Pharma Advances the Registrational Program for Oremepermin Alfa in Japan with Initiation of Additional Phase 3 in Acute Spinal Cord Injury |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.